The post Lady Gaga’s Double Comeback Features A Striking Coincidence appeared on BitcoinEthereumNews.com. Lady Gaga’s “Disease” and “Die With a Smile” both reenter different Billboard charts at No. 15 ahead of the release of her new single, “The Dead Dance.” LAS VEGAS, NEVADA – JULY 16: (Exclusive Coverage) Lady Gaga performs during the kick off of The MAYHEM Ball tour at T-Mobile Arena on July 16, 2025 in Las Vegas, Nevada. (Photo by Kevin Mazur/Getty Images for Live Nation) Kevin Mazur/Getty Images for Live Nation In just a few days, Lady Gaga will release a new single. “The Dead Dance” was written and recorded for Netflix’s series Wednesday, as the singer is set to be featured in season two. The first several episodes of the second installment have already been unveiled, while the rest of the season will be shared on September 3. Ahead of “The Dead Dance” arriving, several of Gaga’s most recent singles return to Billboard charts, and she may experience another surge in the next few frames, thanks to all the excitement around her new track. “Disease” Returns to One Billboard Chart “Disease,” the dark dance-pop tune that helped introduce Gaga’s then-upcoming album Mayhem, is back on the Hot Dance/Pop Songs chart this week. The track, which previously soared to fifth place on one of Billboard’s newest rankings, reappears at No. 15, in last place. “Die with a Smile” Also Reappears in the Same Spot Coincidentally, “Die With a Smile,” Gaga’s collaboration with Bruno Mars, reappears in the same position – No. 15 – only on a different list. The Grammy-winning track reenters the Digital Song Sales chart, Billboard’s ranking of the bestselling cuts of any style throughout the U.S., but only on platforms like iTunes. Luminate reports that “Die With a Smile” returns to the Digital Song Sales list in fifteenth place thanks to almost 1,800 pure purchases. That… The post Lady Gaga’s Double Comeback Features A Striking Coincidence appeared on BitcoinEthereumNews.com. Lady Gaga’s “Disease” and “Die With a Smile” both reenter different Billboard charts at No. 15 ahead of the release of her new single, “The Dead Dance.” LAS VEGAS, NEVADA – JULY 16: (Exclusive Coverage) Lady Gaga performs during the kick off of The MAYHEM Ball tour at T-Mobile Arena on July 16, 2025 in Las Vegas, Nevada. (Photo by Kevin Mazur/Getty Images for Live Nation) Kevin Mazur/Getty Images for Live Nation In just a few days, Lady Gaga will release a new single. “The Dead Dance” was written and recorded for Netflix’s series Wednesday, as the singer is set to be featured in season two. The first several episodes of the second installment have already been unveiled, while the rest of the season will be shared on September 3. Ahead of “The Dead Dance” arriving, several of Gaga’s most recent singles return to Billboard charts, and she may experience another surge in the next few frames, thanks to all the excitement around her new track. “Disease” Returns to One Billboard Chart “Disease,” the dark dance-pop tune that helped introduce Gaga’s then-upcoming album Mayhem, is back on the Hot Dance/Pop Songs chart this week. The track, which previously soared to fifth place on one of Billboard’s newest rankings, reappears at No. 15, in last place. “Die with a Smile” Also Reappears in the Same Spot Coincidentally, “Die With a Smile,” Gaga’s collaboration with Bruno Mars, reappears in the same position – No. 15 – only on a different list. The Grammy-winning track reenters the Digital Song Sales chart, Billboard’s ranking of the bestselling cuts of any style throughout the U.S., but only on platforms like iTunes. Luminate reports that “Die With a Smile” returns to the Digital Song Sales list in fifteenth place thanks to almost 1,800 pure purchases. That…

Lady Gaga’s Double Comeback Features A Striking Coincidence

Lady Gaga’s “Disease” and “Die With a Smile” both reenter different Billboard charts at No. 15 ahead of the release of her new single, “The Dead Dance.” LAS VEGAS, NEVADA – JULY 16: (Exclusive Coverage) Lady Gaga performs during the kick off of The MAYHEM Ball tour at T-Mobile Arena on July 16, 2025 in Las Vegas, Nevada. (Photo by Kevin Mazur/Getty Images for Live Nation)

Kevin Mazur/Getty Images for Live Nation

In just a few days, Lady Gaga will release a new single. “The Dead Dance” was written and recorded for Netflix’s series Wednesday, as the singer is set to be featured in season two. The first several episodes of the second installment have already been unveiled, while the rest of the season will be shared on September 3.

Ahead of “The Dead Dance” arriving, several of Gaga’s most recent singles return to Billboard charts, and she may experience another surge in the next few frames, thanks to all the excitement around her new track.

“Disease” Returns to One Billboard Chart

“Disease,” the dark dance-pop tune that helped introduce Gaga’s then-upcoming album Mayhem, is back on the Hot Dance/Pop Songs chart this week. The track, which previously soared to fifth place on one of Billboard’s newest rankings, reappears at No. 15, in last place.

“Die with a Smile” Also Reappears in the Same Spot

Coincidentally, “Die With a Smile,” Gaga’s collaboration with Bruno Mars, reappears in the same position – No. 15 – only on a different list. The Grammy-winning track reenters the Digital Song Sales chart, Billboard’s ranking of the bestselling cuts of any style throughout the U.S., but only on platforms like iTunes.

Luminate reports that “Die With a Smile” returns to the Digital Song Sales list in fifteenth place thanks to almost 1,800 pure purchases. That sum is up more than 22% from the frame prior.

“Die with a Smile” Lives on Several Tallies

Unlike “Disease,” “Die With a Smile” can be found on more than just the one tally it returns to this week. The Mars/Gaga duet lives on eight rankings at the moment, and one of its lowest positions comes on the sales chart.

“Die With a Smile” is comfortable inside the top 10 on two of Billboard’s pop radio lists, as it holds in second place on the Adult Pop Airplay chart and dips to No. 4 on the Adult Contemporary ranking. “Die With a Smile” is also present inside the top 10 on both of the worldwide rosters and the Radio Songs chart. “Die With a Smile” climbs one space to No. 11 on the Hot 100 after it celebrated its first year on that competitive tally just days ago.

Source: https://www.forbes.com/sites/hughmcintyre/2025/09/01/lady-gagas-double-comeback-features-a-striking-coincidence/

Market Opportunity
Threshold Logo
Threshold Price(T)
$0,009848
$0,009848$0,009848
-0,72%
USD
Threshold (T) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23